State Specialty Directory
Gastroenterology in PA
Federal CMS data for 564 gastroenterology providers across PA. Includes Medicare utilization, Open Payments industry funding, and PECOS enrollment status.
564
Providers
Median industry payments
$2,869
564
Gastroenterology Providers
in PA
$2,869
Median Industry Payments
per provider (2018–2024)
497
Median Medicare Services
fee-for-service claims
How to read this directory: Providers are listed by Medicare service volume, which reflects only
Medicare fee-for-service patients (typically 65+). This does not represent total practice volume.
Industry payments span multiple years and payment types; disclosure alone establishes neither wrongdoing nor legality.
Gastroenterology includes multiple subspecialties with different practice patterns.
Learn more →
Showing top 50 of 564 providers, ranked by Medicare service volume. Search by city to narrow results.
Gastroenterology Providers — PA
NPPES · Open Payments · Medicare| Provider | City | Medicare Volume | Beneficiaries* | Top Procedure | Industry Payments | Payment Type | Coverage |
|---|---|---|---|---|---|---|---|
| HASAN, AHMED MD | Lehighton | 45,603 | — | Vedolizumab infusion (Entyvio) | $9,878 (2018-2024) | — | Very High |
| LUBINSKI, STUART M.D. | Rydal | 19,877 | — | Vedolizumab infusion (Entyvio) | $14,602 (2018-2024) | — | Very High |
| VELASCO, BRENDA MD | Philadelphia | 18,471 | — | Iron infusion (Injectafer) | $2,429 (2018-2024) | — | Very High |
| NACK, STEVEN MD | Flourtown | 13,944 | — | Vedolizumab infusion (Entyvio) | $8,948 (2018-2024) | — | Very High |
| PILCHMAN, JEFFREY M.D. | Bala Cynwyd | 12,260 | — | Vedolizumab infusion (Entyvio) | $5,678 (2018-2024) | — | Very High |
| SMITH, DAVID MD | Lancaster | 9,046 | — | Vedolizumab infusion (Entyvio) | $1,571 (2018-2024) | — | Very High |
| PEYTON, ADAM DO | Allentown | 8,986 | — | Vedolizumab infusion (Entyvio) | $910,767 (2018-2024) | — | Very High |
| BETTERIDGE, JOHN M.D. | Lancaster | 7,502 | — | Vedolizumab infusion (Entyvio) | $275,094 (2018-2024) | — | Very High |
| KAUFMAN, ADAM MD | Malvern | 7,325 | — | Vedolizumab infusion (Entyvio) | $28,970 (2018-2024) | — | Very High |
| HUNTINGTON, WILLIAM | Media | 7,163 | — | Vedolizumab infusion (Entyvio) | $8,347 (2018-2024) | — | Very High |
| MORGAN, MELISSA DO | Lancaster | 6,958 | — | Vedolizumab infusion (Entyvio) | $7,141 (2018-2024) | — | Very High |
| CALLAHAN, NORMAN D.O. | Malvern | 6,850 | — | Vedolizumab infusion (Entyvio) | $7,896 (2018-2024) | — | Very High |
| BLECKER, DANIEL M.D. | Wyomissing | 6,691 | — | Vedolizumab infusion (Entyvio) | $5,662 (2018-2024) | — | Very High |
| JOHNSTON, MARK MD | Lancaster | 6,510 | — | Vedolizumab infusion (Entyvio) | $2,967 (2018-2024) | — | Very High |
| GHANTA, RAVI M.D. | Wyomissing | 6,358 | — | Vedolizumab infusion (Entyvio) | $6,764 (2018-2024) | — | Very High |
| CONNELL, DANIEL MD | Lancaster | 6,337 | — | Vedolizumab infusion (Entyvio) | $5,195 (2018-2024) | — | Very High |
| FRANKEL, ROBERT M.D. | Malvern | 6,227 | — | Vedolizumab infusion (Entyvio) | $18,646 (2018-2024) | — | Very High |
| COOPER, ROBERT D.O. | Wyomissing | 6,194 | — | Vedolizumab infusion (Entyvio) | $1,280 (2019-2024) | — | Very High |
| FINK, SCOTT MD | Wynnewood | 6,107 | — | Vedolizumab infusion (Entyvio) | $244,712 (2018-2024) | — | Very High |
| KOTHARI, RUPAL D.O. | Malvern | 6,089 | — | Vedolizumab infusion (Entyvio) | $57,791 (2018-2024) | — | Very High |
| DEROSA, JUSTIN D.O. | Philadelphia | 5,902 | — | Vedolizumab infusion (Entyvio) | $3,809 (2022-2024) | — | Very High |
| SHNITSER, ANASTASIA MD | Allentown | 5,678 | — | Vedolizumab infusion (Entyvio) | $2,673 (2018-2024) | — | Very High |
| SHELBY, EVAN MD | Lancaster | 5,211 | — | Vedolizumab infusion (Entyvio) | $4,731 (2018-2024) | — | Very High |
| BROSS, RONALD MD | Allentown | 5,029 | — | Vedolizumab infusion (Entyvio) | $399 (2018-2024) | — | Very High |
| PARIKH, AMEET M.D. | Lancaster | 4,985 | — | Vedolizumab infusion (Entyvio) | $5,643 (2018-2024) | — | Very High |
| SPIEGEL, ADAM D.O. | Wyomissing | 4,768 | — | Vedolizumab infusion (Entyvio) | $2,971 (2018-2024) | — | Very High |
| MELE, CARL MD | Wyomissing | 4,652 | — | Vedolizumab infusion (Entyvio) | $2,222 (2018-2024) | — | Very High |
| FARRELL, CHRISTOPHER D.O. | Lancaster | 4,647 | — | Vedolizumab infusion (Entyvio) | $3,398 (2018-2024) | — | Very High |
| ROWE, WILLIAM M.D. | Hershey | 4,376 | — | Infliximab infusion (Remicade) | $1,903 (2018-2024) | — | Very High |
| MELE, APARNA M.D. | Wyomissing | 4,357 | — | Vedolizumab infusion (Entyvio) | $888 (2018-2024) | — | Very High |
| VOLCHONOK, OLEG M.D. | Philadelphia | 3,410 | — | Office visit, established patient (20-29 min) | $107,228 (2018-2024) | — | Very High |
| ARAYA, VICTOR MD | Doylestown | 2,847 | — | Infliximab infusion (Remicade) | $124,347 (2018-2024) | — | Very High |
| YOO, YOUNG-KUL MD | Hazleton | 2,444 | — | Tissue pathology examination, moderate complexity | $5,643 (2018-2024) | — | Very High |
| YOO, JOSEPH M.D. | Hazle Township | 2,409 | — | Tissue pathology examination, moderate complexity | $6,301 (2018-2024) | — | Very High |
| BOYNTON, ROBERT MD | Flourtown | 2,298 | — | Infliximab infusion (Remicade) | $15,692 (2018-2024) | — | Very High |
| ALI, AMAN MD | Edwardsville | 2,242 | — | Upper GI endoscopy with biopsy | $113,640 (2018-2024) | — | Very High |
| REYNOLDS, DAVID M.D. | Honesdale | 2,155 | — | Office visit, established patient (30-39 min) | $309 (2018-2024) | — | Very High |
| JACKSON, FRANK MD | Camp Hill | 2,148 | — | Chronic care management, additional 20 min/month | $10,321 (2018-2024) | — | Very High |
| SAMDANI, BESMA MD | Phoenixville | 2,057 | — | Infliximab infusion (Remicade) | $5,024 (2018-2024) | — | Very High |
| MARKOS, RONALD MD | Sellersville | 1,923 | — | Office visit, established patient (20-29 min) | $5,454 (2018-2024) | — | Very High |
| SUM, EVA M.D. | West Chester | 1,884 | — | Infliximab infusion (Remicade) | $5,630 (2018-2024) | — | Very High |
| VAZE, MILIND M.D. | Huntingdon Valley | 1,882 | — | Hospital follow-up visit, moderate complexity | $8,609 (2018-2024) | — | Very High |
| BRUNO, JOSEPH M.D. | Rydal | 1,874 | — | Infliximab infusion (Remicade) | $876 (2018-2024) | — | Very High |
| HOPKINS, MARC MD | Colmar | 1,810 | — | Infliximab infusion (Remicade) | $6,440 (2018-2024) | — | Very High |
| LUKASZEWSKI, KATHLEEN DO | Sellersville | 1,777 | — | Colon polyp removal with endoscopic snare | $4,942 (2018-2024) | — | Very High |
| MERMELSTEIN, ALAN MD | Phila | 1,741 | — | Hospital follow-up visit, moderate complexity | $4,621 (2018-2024) | — | Very High |
| MICHEL, JOHN DO | Camp Hill | 1,715 | — | Office visit, established patient (30-39 min) | $699 (2018-2024) | — | Very High |
| LACEY, PAUL M.D. | Harrisburg | 1,655 | — | Office visit, established patient (30-39 min) | $368 (2018-2024) | — | Very High |
| TATERKA, JAMES MD | Flourtown | 1,632 | — | Chronic care management, additional 20 min/month | $6,546 (2018-2024) | — | Very High |
| SHIH, CHRISTOPHER M.D. | Lancaster | 1,518 | — | Infliximab infusion (Remicade) | $5,091 (2018-2024) | — | Very High |
Note: Gastroenterology encompasses multiple subspecialties with different practice patterns.
Differences in payment amounts and procedure volumes may reflect subspecialty focus
rather than practice quality. Consider viewing individual profiles for full context.